1-4 of 4
Yann-Erick Claessens
Close
Sort by
Journal Articles

Performance of Age-Adjusted D-Dimer Cut-off Values to Rule Out Venous Thromboembolism in Patients with Non-High Pre-Test Probability

Pierre A. Toulon, MD, PhD, Yann-Erick Claessens, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1147.
https://doi.org/10.1182/blood.V120.21.1147.1147
Published: 2012
Journal Articles

Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD

Yann-Erick Claessens, Sophie Park, Anne Dubart-Kupperschmitt, Virginie Mariot, Carmen Garrido, Stany Chrétien, François Dreyfus, Catherine Lacombe, Patrick Mayeux, Michaëla Fontenay
Journal: Blood
Blood (2005) 105 (10): 4035–4042.
https://doi.org/10.1182/blood-2004-08-3166
Published: 2005
Journal Articles

Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation

Didier Bouscary, Frédéric Pene, Yann-Erick Claessens, Odile Muller, Stany Chrétien, Michaëla Fontenay-Roupie, Sylvie Gisselbrecht, Patrick Mayeux, Catherine Lacombe
Journal: Blood
Blood (2003) 101 (9): 3436–3443.
https://doi.org/10.1182/blood-2002-07-2332
Published: 2003
Journal Articles

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis

Yann-Erick Claessens, Didier Bouscary, Jean-Michel Dupont, Françoise Picard, Josiane Melle, Sylvie Gisselbrecht, Catherine Lacombe, François Dreyfus, Patrick Mayeux, Michaëla Fontenay-Roupie
Journal: Blood
Blood (2002) 99 (5): 1594–1601.
https://doi.org/10.1182/blood.V99.5.1594
Published: 2002